Market-Moving News for March 28th
Market-Moving News for March 28th
3月28日市场动向新闻
AVTX: 406% | Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
AVTX：406% | Avalo 收购抗 IL-1β MAB 并宣布高达 1.85 亿美元的私募融资
XLO: 399% | Xilio Therapeutics shares are trading higher after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing.
XLO：399％ | Xilio Therapeutics宣布与吉利德科学签订肿瘤激活的 IL-12 计划的独家许可协议后，该公司股价走高。该公司宣布了1130万澳元的私募股权融资。
BDRX: 46% | Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers
BDRX：46% | Biodexa 的 MTX110 有望延长对抗侵袭性脑癌的预期寿命